Brief: Sanuwave Receives FDA De Novo Decision To Immediately Market Dermapace System For Treatment Of Diabetic Foot Ulcers In U.S.

SANUWAVE Health

02/01/2018 13:04

Jan 2 (Reuters) - Sanuwave Health Inc  SNWV.PK : 
    * SANUWAVE RECEIVES FDA DE NOVO DECISION TO IMMEDIATELY 
MARKET THE 
DERMAPACE SYSTEM FOR THE TREATMENT OF DIABETIC FOOT ULCERS IN 
THE U.S. 
 
Source text for Eikon:  ID:nGNXOLKMYa  
Further company coverage:  SNWV.PK  
 
 ((Bangalore.newsroom@thomsonreuters.com;))